+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Neutropenia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768130
  • Report
  • 219 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Apotex Inc
  • Astellas Pharma Inc
  • Intas Pharmaceuticals Ltd
  • Kirin Holdings Co Ltd
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Neutropenia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neutropenia. It presents in-depth analysis of Neutropenia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Neutropenia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Neutropenia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Neutropenia

The research work is prepared through extensive and continuous research on Neutropenia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Neutropenia patients are identified
  • The report includes panorama of Neutropenia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Neutropenia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Apotex Inc
  • Astellas Pharma Inc
  • Intas Pharmaceuticals Ltd
  • Kirin Holdings Co Ltd
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Neutropenia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Neutropenia Clinical Trials by Region
2.2.2 Average Enrollment of Neutropenia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Neutropenia Treatment, 2019

3. Region wise Neutropenia Clinical Trials
3.1 Asia Pacific Neutropenia Clinical Trials by Country
3.2 Europe Neutropenia Clinical Trials by Country
3.3 North America Neutropenia Clinical Trials by Country
3.4 Middle East and Africa Neutropenia Clinical Trials by Country
3.5 South and Central America Neutropenia Clinical Trials by Country

4. Neutropenia Clinical Trial Trends
4.1 Start Year wise Neutropenia Clinical Trials
4.2 Phase wise Neutropenia Clinical Trials
4.3 Trial Status wise Neutropenia Clinical Trials
4.4 Trial Type wise Neutropenia Clinical Trials

5. Neutropenia Average Enrollment Trends
5.1 Average Enrollment in Neutropenia Trials by Year
5.2 Average Enrollment in Neutropenia Trials by Phase
5.3 Average Enrollment in Neutropenia Trials by Status
5.4 Average Enrollment in Neutropenia Trials by Type of Trial

6. Companies Participating in Neutropenia Clinical Trials
6.1 Neutropenia Trials by Sponsor Type
6.2 Neutropenia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Neutropenia Trials- Phase 1
7.2 Neutropenia Trials- Phase 2
7.3 Neutropenia Trials- Phase 3
7.4 Neutropenia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Neutropenia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Neutropenia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Neutropenia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Neutropenia Clinical Trials and Enrolment
Figure 7: North America - Country wise Neutropenia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Neutropenia Clinical Trials and Enrolment
Figure 9: Neutropenia Clinical Trials by Phase
Figure 10: Neutropenia Clinical Trials by Trial Status
Figure 11: Neutropenia Clinical Trials by Type
Figure 12: Neutropenia Clinical Trials by Sponsor Type
Figure 13: Neutropenia Clinical Trials by Leading Sponsors
Figure 14: Neutropenia Average Enrollment by Phase
Figure 15: Neutropenia Average Enrollment by Trial Status
Figure 16: Neutropenia Average Enrollment by Type
Figure 17: Neutropenia- Average Enrolment by Type of Sponsors
Figure 18: Neutropenia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Neutropenia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Neutropenia Clinical Trials and Enrolment
Table 5: Europe - Country wise Neutropenia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Neutropenia Clinical Trials and Enrolment
Table 7: North America - Country wise Neutropenia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Neutropenia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Neutropenia Average Enrollment by Phase
Table 15: Neutropenia Average Enrollment by Trial Status
Table 16: Neutropenia Average Enrollment by Type
Table 17: Neutropenia- Average Enrolment by Type of Sponsors
Table 18: Neutropenia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Amgen Inc
  • Apotex Inc
  • Astellas Pharma Inc
  • Generon (Shanghai) Corp Ltd
  • Intas Pharmaceuticals Ltd
  • Kirin Holdings Co Ltd
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768130
Adroll
adroll